Immix Biopharma (IMMX) Debt Ratio (2020 - 2022)
Immix Biopharma's (IMMX) Debt Ratio stood at 0.00 in Q1 2022, down 9.1% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Debt Ratio (2020 - 2022) Analysis & Trends
- Across earlier years, Debt Ratio came in at 7.60 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 0.31 |
| 10 | Immix Biopharma | 531.85 Mn | 299.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Dec 31, 2020 | 7.60 |
API Access
Immix Biopharma Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();